Journal of General Internal Medicine

, Volume 25, Issue 1, pp 3–4

Medicare Part D—Lessons Learned and Guidance for Health-care Reform

Editorial
  • 66 Downloads

References

  1. 1.
    Safran DG, Strollo MK, Guterman S, Li A, Rogers WH, Neuman P. Prescription coverage, use, and spending before and after Part D implementation: a national longitudinal panel study. J Gen Intern Med. 2009;169(8):740-8.Google Scholar
  2. 2.
    Shrank WH, Patrick AR, Pedan A, et al. The effect of transitioning to Medicare Part D drug coverage in seniors dually eligible for Medicare and Medicaid. J Am Geriatr Soc. 2008;56(12):2304–10.CrossRefPubMedGoogle Scholar
  3. 3.
    Keenan TA. Experiences with Medicare Part D among enrollees and non-enrollees. 2006. Available at: http://assets.aarp.org/rgcenter/health/medicare_part_d.pdf. Accessed August 10, 2009.
  4. 4.
    Skarupski KA, Mendes de Leon CF, Barnes LL, Evans DA. Medicare Part D enrollment in a biracial community-based population of older adults. Gerontologist. 2009;49(6):828–38.CrossRefPubMedGoogle Scholar
  5. 5.
    Winter J, Balza R, Caro F, et al. Medicare prescription drug coverage: consumer information and preferences. Proc Nat Acad Sci USA. 2006;103(20):7929–34.CrossRefPubMedGoogle Scholar
  6. 6.
    Zhang Y, Donohue JM, Lave JR, O'Donnell GO, Newhouse JP. The effect of Medicare Part D on drug and medical spending. N Engl J Med. 2009;36(1):52–61.CrossRefGoogle Scholar
  7. 7.
    Raebel MA, Delate T, Ellis JL, Bayliss EA. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Med Care. 2008;46(10):1116–22.CrossRefPubMedGoogle Scholar
  8. 8.
    Schneeweiss S, Patrick AR, Pedan A, et al. The effect of Medicare Part D drug coverage on drug use and cost-sharing in seniors without prior drug benefits. Health Aff. 2009;28(2):w305–w316.CrossRefGoogle Scholar
  9. 9.
    Zhang Y, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff. 2009;28(2):w317–w325.CrossRefGoogle Scholar
  10. 10.
    Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349–59.CrossRefPubMedGoogle Scholar
  11. 11.
    GovTrack.us. Text of H.R. 6331 [110th]: Medicare improvements for Patients and Providers Act of 2008. Available at: http://www.govtrack.us/congress/billtext.xpd?bill=h110-6331&version=enr&nid=t0%3Aenr%3A242. Accessed October 1, 2009.
  12. 12.
    Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circ. 2008;117(10):1261–8.CrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2009

Authors and Affiliations

  1. 1.Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s HospitalBostonUSA
  2. 2.Harvard Medical SchoolBostonUSA

Personalised recommendations